ATRA beat EPS expectations by 67.37%
Mar 13, 2025, 10:35 PM
0.00%
What does ATRA do
Atara Biotherapeutics, headquartered in Thousand Oaks, California, is a biotechnology company specializing in allogeneic T-cell immunotherapy, with products like Ebvallo and ATA3219 in various development stages. The company went public on October 16, 2014, and employs 173 staff.
Atara Biotherapeutics (ATRA) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Atara Biotherapeutics's actual EPS was -$1.19, beating the estimate of -$3.65 per share, resulting in a 67.37% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.